CBD Interactions with Warfarin

Introduction to CBD-Warfarin Interactions

CBD gummies can potentially interact with warfarin by inhibiting CYP2C9 metabolism, leading to increased INR values and bleeding risk in patients, so close monitoring is recommended if concurrent use cannot be avoided 1
The American Heart Association recommends avoiding concurrent use of CBD gummies and warfarin due to potential interaction, as a first-line approach 1

CBD interacts with warfarin through CYP450 Enzyme Inhibition, specifically inhibiting CYP2C9, the primary enzyme responsible for metabolizing the more potent S-isomer of warfarin in patients on warfarin therapy 1
This inhibition can lead to higher plasma concentrations of warfarin, potentially increasing INR values and bleeding risk in individuals taking warfarin 1

Genetic variations in CYP2C9 metabolism may make some patients more susceptible to the CBD-warfarin interaction, highlighting the need for personalized monitoring 1
The Mayo Clinic recommends considering the potential bleeding risk associated with CBD use, even without significant INR changes, due to its independent antiplatelet effects 2
If concurrent use of CBD and warfarin cannot be avoided, increasing the frequency of INR monitoring, especially during the first 2 weeks, and considering a preemptive warfarin dose reduction of 20-30% may be necessary 1

Higher CBD doses appear to have a greater potential for interaction with warfarin, and the route of administration may also impact the degree of interaction, with oral forms like gummies potentially having a greater effect due to first-pass metabolism 1
Consistent CBD dosing is crucial to avoid unpredictable INR fluctuations in patients on warfarin therapy 1